Transthyretin (ATTR-CM) and light-chain cardiac amyloidosis trial coverage from The Rhythm.
Structural Heart & TAVI
Issue 23 | Week of 7th September 2026 ESC Congress 2026 concluded in Munich on 31 August. This issue covers papers first published on 30 and 31 August, plus CARDIO-TTRansform, first published on 28 August and held over from last issue by editorial choice. Cardiology Intelligence Briefing: what a result
Lipids & Prevention
Issue 20 | Week of 17th August 2026 No major cardiology congress fell this week. The strongest evidence came from The Lancet Healthy Longevity, JACC's special issue on obesity, JAMA Cardiology, and the European Heart Journal. Cardiology Intelligence Briefing: the trouble with average Cardiovascular evidence keeps hitting the same
Structural Heart & TAVI
Issue 13 | Week of 29 June 2026 No major cardiology congress fell this week, so the most consequential evidence arrived through journal publication. The thread running through it was time and trust: which of our habits hold up over the long run, which can be safely let go, and which
Heart Failure
Issue 7 | Week of 18 May 2026 Heart Failure 2026 closed in Barcelona on 12 May. The week that followed is lighter on the congress calendar but heavier on the questions large trials are not designed to answer. Cardiology Intelligence Briefing: between the landmarks Landmark cardiovascular trials earn their authority